STERIS plc
STERIS plc (STE) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ste · pe ratio · data through Mar 31, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for STERIS plc (STE) measures how much investors pay for each dollar of the company's trailing earnings. STE's current PE ratio of 26.31x is calculated by dividing its stock price of $210.03 by its TTM earnings per share of $7.98. −66.8% discount vs 5Y avg 79.3x
Source: FMP · /ratios-ttm · /analyst-estimates · 2026-03-31
PE Ratio History
2007 – 2026 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 20 fiscal years · Front-end computedMinQ1 · 25%30.0x
MedianQ3 · 75%178.2x
Max
At 26.31x, STE's current P/E is within its average historical range over the past 20 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
STERIS plcYou STE | $20.5B | 26.31x | -21.0% | $7.98 |
 Biogen Inc. BIIB | $28.4B | 19.96x | -40.1% | $8.82 |
 Quest Diagnostics Incorporated DGX | $21.8B | 19.42x | -41.7% | $8.94 |
 DexCom, Inc. DXCM | $29.6B | 30.97x | -7.0% | $2.14 |
 Labcorp Holdings Inc. LH | $21.5B | 23.81x | -28.5% | $10.53 |
 Koninklijke Philips N.V. PHG | $25.1B | 24.78x | -25.6% | $0.93 |
 Insulet Corporation PODD | $10.5B | 80.92x | +142.9% | $3.51 |
Industry Average 6 peers with valid PE | — | 33.31x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2026-03-31Latest FY2026 | 27.66x | $7.99 | -23.9% | |
2025-03-31 FY2025 | 36.35x | $6.24 | -37.0% | |
2024-03-31 FY2024 | 57.73x | $3.83 | -67.6% | |
2023-03-31 FY2023 | 178.19x | $1.07 | +84.3% | |
2022-03-31 FY2022 | 96.69x | $2.50 | +136.8% | |
2021-03-31 FY2021 | 40.84x | $4.66 | +40.3% | |
2020-03-31 FY2020 | 29.11x | $4.81 | -17.9% | |
2019-03-31 FY2019 | 35.45x | $3.59 | +29.9% | |
2018-03-31 FY2018 | 27.29x | $3.42 | -49.5% | |
2017-03-31 FY2017 | 53.99x | $1.29 | +19.1% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for STERIS plc (STE) measures how much investors pay for each dollar of the company's trailing earnings. STE's current PE ratio of 26.31x is calculated by dividing its stock price of $210.03 by its TTM earnings per share of $7.98.
Frequently asked questions
STE pe ratio · 6 questionsSTE's current PE ratio is 26.31x as of 2026-06-08, based on a stock price of $210.03 and TTM EPS of $7.98. Data sourced from Financial Modeling Prep via STE's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · STERIS plc SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08